Prime Medicine, Inc. <PRME.O>: BMO initiates coverage with outperform rating; price target $9
PRME•Related News
Palo Alto Networks, Inc. <PANW.O>: Truist Securities Raises Target Price to $435 From $375
PANW•
Pentair Pool integrates Pool Brain software with IntelliFlo3 pump data stream
PNR•
Exelixis Inc <EXEL.O>: BMO initiates coverage with market perform rating; price target $54
EXEL•
Analog Devices FY26 Q3 diluted EPS more than doubled to $2.74; revenue rises 40% to $4.02 billion
ADI•
Platelets can be chilled and stored for weeks, not days, study shows
XLV•